PF4 and systemic sclerosis: The data reveals that anti-CXCL4 antibody autoreactivity is present in a consistent proportion of SSc patients and correlates with IFN-α, while T-cells also recognized CXCL4 as an autoantigen, suggesting T-cell help for autoantibody production.